U. Nindra

发表

Elevated neutrophil‐to‐lymphocyte ratio (NLR) is associated with poorer progression‐free survival in unresectable stage III NSCLC treated with consolidation durvalumab

A. Nagrial, Jenny H. Lee, S. Kao, 2022, Thoracic cancer.

Review of systemic chemotherapy in unresectable colorectal peritoneal carcinomatosis

K. Mahon, A. Shahnam, U. Nindra, 2021, Asia-Pacific journal of clinical oncology.

028 Delayed CT imaging leading to delays in acute stroke management in regional australia

U. Nindra, K. Fuller, Toni M Wonson, 2019, Journal of Neurology, Neurosurgery, and Psychiatry.

Concurrent Paraneoplastic Dermatomyositis and Acquired C1 Esterase Inhibitor Deficiency in Primary Laryngeal Small Cell Carcinoma

V. Bray, K. Nguyen, E. Moylan, 2021, Case Reports in Oncology.

Influence of EGFR mutation status and PD-L1 expression in stage III unresectable non-small cell lung cancer treated with chemoradiation and consolidation durvalumab.

A. Nagrial, Jenny H. Lee, S. Kao, 2022, Asia-Pacific journal of clinical oncology.

Review of Toxicities of PARP Inhibitors in Metastatic Castrate Resistant Prostate Cancer.

W. Chua, Udit Nindra, B. Balakrishnar, 2022, Clinical genitourinary cancer.

A systematic review of neoadjuvant and definitive immunotherapy in locally advanced head and neck squamous cell carcinoma

Jia Liu, V. Chin, D. Forstner, 2023, Cancer medicine.

A Rare Case of Castrate-Resistant Prostate Adenocarcinoma with a Unilateral Testicular Metastasis Mimicking a Primary Testicular Tumour

B. Balakrishnar, J. Hong, P. Gassner, 2022, Case Reports in Oncology.

Precision medicine in Australia: now is the time to get it right

C. Lee, Abhijit Pal, U. Nindra, 2023, The Medical journal of Australia.

Time Equals Brain - Retrospective Analysis of Thrombolysis in Regional Australia to Determine Factors which Influence Door to Needle Time

Udit Nindra, Karen Fuller, U. Nindra, 2019, Archives in Neurology & Neuroscience.

Objective response rate and progression-free survival as surrogates for overall survival treatment effect: A meta-analysis across diverse tumour groups and contemporary therapies.

S. Luen, M. Sorich, A. Hopkins, 2023, European journal of cancer.

Utility of multigene panel next-generation sequencing in routine clinical practice for identifying genomic alterations in newly diagnosed metastatic nonsmall cell lung cancer.

W. Chua, U. Nindra, V. Lea, 2023, Internal medicine journal.

Multigene panel next generation sequencing in metastatic colorectal cancer in an Australian population

R. Asghari, W. Chua, U. Nindra, 2023, PloS one.

The histopathological spectrum and molecular changes associated with KRAS G12C mutation in non-small cell lung carcinoma

U. Nindra, Abhijit Pal, Victoria Bray, 2024, Pathology.

Variations in patterns of prescribing durvalumab in stage III lung cancer: a survey of Australian Medical Oncologists.

D. Karikios, U. Nindra, Abhijit Pal, 2024, Oncology.

Survival outcomes in older adults undergoing early phase clinical trials.

U. Nindra, W. Chua, S. Childs, 2024, Journal of geriatric oncology.

A case for the use of chemotherapy in hereditary mitochondrial optic neuropathies: Successful administration of cisplatin/etoposide in a male patient with testicular seminoma and Leber's hereditary optic neuropathy

U. Nindra, Jean‐Luc Vrisakis, Clare L. Fraser, 2024, Clinical case reports.